Product Detail
(1S,2S,3R,5S)-3-(5-Amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane
Ticagrelor Impurity
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Impurity
API Family
Ticagrelor
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
(1S,2S,3R,5S)-3-(5-Amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane Product Information
(1S,2S,3R,5S)-3-(5-Amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane is listed under Impurity. It is associated with Ticagrelor and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-65978.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
(1S,2S,3R,5S)-3-(5-Amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane
CAS No.
1402150-32-6
CAT No.
CS-T-65978
Molecular Formula
C14H23ClN4O4S
Molecular Weight
378.87
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
CCCSC1=NC(N[C@@H]2C[C@@H]([C@H]([C@H]2O)O)OCCO)=C(C(Cl)=N1)N
IUPAC Name
(1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Hazard Compound
Refer MSDS for complete information.
Description
Overview
(1S,2S,3R,5S)-3-(5-amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol is an impurity of Ticagrelor which is an anticoagulant used in the treatment of acute coronary syndromes.
Synonyms
Ticagrelor Related Compound 57
Application Notes
(1S,2S,3R,5S)-3-(5-amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol is an impurity of Ticagrelor which is an anticoagulant used in the treatment of acute coronary syndromes.
